Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40.3M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
9.17M
-
Shares change
-
-137K
-
Total reported value, excl. options
-
$10.4M
-
Value change
-
-$135K
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$1.25
Significant Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q3 2025
18 filings reported holding BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share as of Q3 2025.
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.17M shares
of 40.3M outstanding shares and own 22.76% of the company stock.
Largest 10 shareholders include M&G PLC (5.2M shares), Alphabet Inc. (1.51M shares), HSG Holding Ltd (1.42M shares), DC Funds, LP (642K shares), Johns Hopkins University (122K shares), Baird Financial Group, Inc. (107K shares), RENAISSANCE TECHNOLOGIES LLC (66.3K shares), HighTower Advisors, LLC (37.5K shares), HRT FINANCIAL LP (20.2K shares), and Janney Montgomery Scott LLC (15.4K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.